Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Pemetrexed Plus Cisplatin as Combination Chemotherapy for Post-operative Adenocarcinoma : Multi-center, Single Arm, Open-label, Phase Ⅱ Trial

NCT02498860 is registered in ClinicalTrials.gov with Chonnam National University Hospital as lead sponsor.

NCT NCT02498860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02498860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Pemetrexed Plus Cisplatin as Combination Chemotherapy for Post-operative Adenocarcinoma : Multi-center, Single Arm, Open-label, Phase Ⅱ Trial
Lead sponsor
Chonnam National University Hospital
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2015
Completion date
July 31, 2021
Enrollment
106 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, lung neoplasm